NF1 inactivating mutations were found in 48% of a cohort of wild-type BRAF and NRAS melanomas and are often associated with mutations in other RAS-related genes such as RAS p21 protein activator 2 (RASA2), PTPN11, and SPRED1 (25, 40). The gene discussed is BRAF; the disease is melanoma.